Some analysts less favorable towards News Corp (Reuters)
Reuters - News Corp. shares have been Wall Street favorites in recent years, but in recent days a couple of analysts have cut their rating and/or price target on the media conglomerate’s stock, citing growth concerns, particularly at its online assets, led by MySpace.
More: continued here Buy Fluvoxamine
Buy Oxazepam
Buy Iodine
Buy Promazine
Buy Lyrica
Buy Echothiophate
Buy Quazepam
Buy Diatrizoate
Buy Ciprofloxacin
Buy Iodipamide
Buy Proguanil
Buy Amoxil
Buy Dilantin
Buy Dimethothiazine
Buy Flutamide
Buy Suboxone
Buy Isoflurophate
Buy Rifampin
Buy Chlorcyclizine
Buy Metrizoate
Buy Cefadroxil
Buy Bepridil
Buy Nadroparin
Buy Milrinone
Buy Hydromorphone
Buy Clonidine
Buy Eprosartan
Buy Flurazepam
Buy Viagra
Buy Losartan
Buy Cephalexin
Buy Amrinone
Buy Ramipril
Buy Prozac
Buy Piperacillin
Buy Zyban
Buy Toradol
Buy Hydrocodone
Buy Marijuana
Buy Yasmin
Buy Tolmetin
Buy Metolazone
Buy Echinacea
Buy Pentoxifylline
Buy Robaxin
Buy Minocin
Buy Triprolidine
Buy Accolate
Buy Chloroquine
Buy Methylergonovine
Buy Cyclizine
Buy Dothiepin
Buy Moxalactam
Buy Timolol
Buy Noctec
Buy Trandolapril
Buy Vicodin
Buy Lisinopril
Buy Mifepristone
Buy Iodoxamate
Buy Senna
Buy Nicotrol
Buy Saquinavir
Buy Differin
Buy Cerivastatin
Buy Molindone
Buy Orphenadrine
Buy Aprotinin
Buy Streptomycin
Buy Cocaine
Buy Clarithromycin
Buy Methantheline
Buy Androgel
Buy Efavirenz
Buy Vidarabine
Buy Clofazimine
Buy Propafenone